Lobbying Information
Subject Matters
- Aboriginal Affairs
- Budget
- Economic Development
- Health
- Industry
- Intellectual Property
- International Trade
- Research and Development
- Science and Technology
- Taxation and Finance
Subject Matter Details
Legislative Proposal, Bill or Resolution, Policies or Program
- Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals
Legislative Proposal, Bill or Resolution, Policies or Program, Regulation
- Legislation, regulation and policies related to international trade agreements, specifically, the development of legislation and regulations to implement the terms of the Comprehensive Economic and Trade Agreement and the Trans-Pacific Partnership
Legislative Proposal, Bill or Resolution, Regulation
- Food and Drugs Act and Regulations and policies, encompassing all elements that relate to the approval, regulation and life-cycle management of therapeutic products
- Patent Act and Regulations and policies related to pharmaceuticals, including the all aspects related to Patented Medicine Prices Review Board with respect to the regulation of pricing of patented medicines and the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations
Policies or Program
- Federal drug plans, with respect to decisions and policies that affect the reimbursement of therapeutic products for plan beneficiaries, particularly the Non-Insured Health Benefits Program (Health Canada)
- Health Canada pharmaceutical policy, particularly as it relates to participating in, supporting and directing federal, national and interjurisdictional activities
- Innovation, Science and Economic Development Canada policies related to life sciences, research and development and science and technology-related strategies, including consultations on and development of Canada’s Innovation Agenda
- Policies and programs related to Indigenous health matters, specifically, community-based health promotion and disease prevention programs
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Finance Canada (FIN)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Indigenous and Northern Affairs Canada
-
Innovation, Science and Economic Development Canada (ISED)
-
Patented Medicine Prices Review Board (PMPRB)
-
Senate of Canada
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
300-2680 Skymark Avenue
Mississauga, ON L4W 5L6
Canada
Telephone number:
905-629-4222
Client representative
Lindsay Williams, Sr. Public Affairs Manager, President's Group
Parent Company Information
- Novo Nordisk A/S
-
Novo Allé 1
Bagsvaerd 2880
Denmark
Coalition Members Information
Novo Nordisk Canada Inc. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Novo Nordisk Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Novo Nordisk Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
WILLIAM DEMPSTER
|
Public offices held
Business address:
130 Albert St.
Suite 408
OTTAWA, ON K1P 5G4
Canada
Telephone number:
613-614-0283
Fax number:
613-249-3645
Consultant Firm and Address
Firm:
3Sixty Public Affairs Inc. / 3Sixty Public Affairs Inc.
Address:
130 Albert Street
Suite 408
Ottawa, ON K1P 5G4
Canada
Telephone number:
613-800-8340
Fax number:
613-800-8343
